Sector revisions Perspective Therapeutics, Inc.

Stocks

Real-time Estimate Cboe BZX 11:52:02 2026-09-29 EDT			5-day change	1st Jan Change
2.525 ^USD	+1.00%		-15.03%	-8.55%

09-20	Perspective Therapeutics, Inc.(NYSEAM:CATX) dropped from S&P Biotechnology Select Industry Index	CI
09-18	William Blair Initiates Perspective Therapeutics With Outperform Rating	MT

Add to a list 0 selected To use this feature you must be a member Log in Sign up	1y. EPS revision	Nbr of analysts
PERSPECTIVE THERAPEUTICS, INC.		14
LONZA GROUP AG		23
IQVIA HOLDINGS INC.		18
REVOLUTION MEDICINES, INC.		23
BEONE MEDICINES AG		28
CELLTRION, INC.		22
MEDPACE HOLDINGS, INC.		12
TEMPUS AI, INC.		18
EUROFINS SCIENTIFIC SE		14
ASCENDIS PHARMA A/S	-	20
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.		14
ICON PUBLIC LIMITED COMPANY		16
GENSCRIPT BIOTECH CORPORATION		7
BIO-TECHNE CORPORATION		11
PHARMARON BEIJING CO., LTD.		11
KYMERA THERAPEUTICS, INC.		22
PROTAGONIST THERAPEUTICS, INC.		13
QIAGEN N.V.		15
ABIVAX		7
PRAXIS PRECISION MEDICINES, INC.		19
Average		16
Weighted average by Cap.		19